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A B S T R A C T
The study evaluated antioxidant status in patients with peripheral vascular disease
(PVD), with and without concomitant diabetes mellitus (DM). 211 participants were di-
vided into standardized 4 groups: patients with PVD and DM (PVD+DM+), patients
with PVD without DM (PVD+DM-), patients without PVD with DM (PVD-DM+) and
patients without PVD and DM (PVD-DM-). The diagnosis of PVD was established by
Doppler sonography analysis, including determination of the ankle brachial index (ABI),
partial pressures along the leg, and CW Doppler sonography at typical locations. Anti-
oxidant status has been evaluated through the colorimetrically assessed serum activity
of key antioxidant enzymes: superoxide dismutase (SOD), catalase, and glutathione pe-
roxidase (GLPX) as well as through total antioxidant status (TAS) determination. In
PVD+DM- group, as well as PVD-DM+ group, a significantly lower activity of the GLPX,
catalase and TAS was found, whereas activity of SOD was significantly higher. There
was no statistically significant difference between PVD+DM+ and PVD-DM+ group. Li-
kewise, there was no statistically significant difference between PVD+DM- and PVD
-DM-group. This study has shown that there is statistically significant difference in ac-
tivity of antioxidant enzymes between diabetic and non-diabetic patients, irrespectively
of PVD presence. Furthermore, PVD present alone does not alter key antioxidant en-
zymes activity in comparison with healthy subjects.
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Introduction
Oxidative stress is defined as a shift in
balance in cellular oxidation-reduction
reactions in favor of oxidation. This leads
to damage of the cell and formation of mo-
lecular products that are indicators of ox-
idative stress1. The rise in oxidative stress
can be caused by hyper production of re-
active forerunners of oxygen radicals or
due to the decrease in activity of scaven-
gers in the defense antioxidant system.
Oxidative stress develops when an in-
creased production of free radicals ex-
ceeds anti-oxidation defense, which then
results in tissue damage2.
Aerobic organisms have developed pro-
tection and defense mechanisms against
oxidants and free radicals during their
evolution. Antioxidant is a substance
that protects the biological tissue from
damage due to free radicals, and can be
recycled or regenerated by biological re-
ducers2. The system includes numerous
enzyme and non-enzyme type of antioxi-
dant groups that are located in the cell
and in the extracellular fluid.
Antioxidant system is an integrated
defense network with many different me-
chanisms for protection and repair cau-
sed by oxidative damage. Enzymes have
the key role in this defense from oxidative
stress. The three most important antioxi-
dant enzymes are: superoxide dismutase
(SOD), catalase, and glutathione peroxi-
dase (GLPX)1.
Chronic complications of diabetes mel-
litus (DM) represent the main cause of in-
fection and death in diabetic patients3,4
even in the absence of hypertension, smo-
king and hyperlipidemia5. Those compli-
cations are heterogeneous groups of clini-
cal disturbances that attack the vascular
system, kidneys, retina, peripheral ner-
ves, lens, skin, and present the main
threat to the quality and length of life in
diabetic patients4.
DM represents the state of increased
oxidative stress, based on increased pero-
xidation and reduced antioxidant status6.
Oxidative stress is also a recognized pa-
thogenic mechanism in diabetic compli-
cations7.
The goal of this study is to analyze the
antioxidant status in patients with pe-
ripheral vascular disease (PVD), both
those with and without presence of DM.
Subjects and Methods
The study includes 4 groups of partici-
pants whose antioxidant status has been
determined:
I. composed of 53 participants with PVD
and with DM (PVD+ DM+);
II. composed of 59 participants with PVD
and without DM (PVD+ DM-);
III. composed of 56 participants without
PVD and with DM (PVD- DM+);
IV. composed of 43 participants without
PVD and without DM (PVD- DM-).
All study groups were standardized
according to parameters included in indi-
vidual patient index card such as age,
sex, body mass index (BMI), type and du-
ration of DM, anti-diabetic treatment and
also laboratory findings about fasting
plasma glucose concentration and HbA1C.
Assessment of macrocirculation of lower
extremities was performed using the stan-
dard Doppler sonography analysis, which
includes the CW Doppler sonography at
typical locations, determining the ankle
brachial index (ABI), and measuring par-
tial pressures at four levels along the leg.
CW Doppler sonography device, Vasoscan
VL from a British company Oxford/Soni-
caid, was used for this purpose.
Diagnosis of PVD is established for
ABI values less than 0.9. Isolated partial
disease has ABI values greater than 0.5.
ABI values smaller than 0.5 indicate
multisegmental obliterative disease. Sys-
tolic partial pressures that are determi-
ned at four levels along the leg are used
in estimating stenosis localization, and
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all are usually greater than the brachial
pressure. The allowable vertical pressure
gradient between adjacent segments does
not exceed 30 mm Hg.
Serum samples obtained for the pur-
pose of the study were frozen immedi-
ately. Measuring the serum activity of
key antioxidant enzymes: SOD, catalase
and GLPX, as well as TAS was done by
using colorimetrical Randox kits (Randox
Laboratories Ltd, United Kingdom) and
expressed in IU/l, kIU/l, IU/ml and
mmol/l, respectively.
Statistical analysis was done on a com-
puter using the software STATISTICA for
Windows, ver. 5.5., Tulsa, StatSoft, Inc.
2000. Testing the difference between groups
utilized the Kruskal-Wallis. Testing three
or more numerical characteristics was do-
ne by using the Mann-Whitney test.
Results
Figure 1 shows the distribution of se-
rum GLPX activity for four observed
groups. Using the Kruskal-Wallis test,
statistically significant difference has been
shown between groups (p<0.001). GLPX
activity is significantly lower in diabetic
patients than in groups without DM.
Figure 2 shows the distribution of se-
rum catalase activity for four observed
groups. Statistically significant differen-
ce has been shown between groups (p=
0.003). Catalase activity is significantly
lower in PVD-DM+ group, while non-dia-
betic patients have higher catalase activ-
ity.
Figure 3 shows the distribution of TAS
activity in serum for four observed groups.
Statistically significant difference has been
shown between groups (p<0.001). TAS ac-
tivity is significantly lower in diabetic pa-
tients than in groups without DM.
Figure 4 shows the distribution of se-
rum SOD activity for four observed groups.
Using the Kruskal-Wallis test, statisti-
cally significant difference has been shown
between groups (p<0.001). SOD activity
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Fig. 1. Distribution of serum glutathione peroxidase (GLPX) activity for four observed subject groups:
with PVD and with DM (PVD+DM+), with PVD and without DM (PVD+DM-), without PVD and
with DM (PVD-DM+), and without PVD and without DM (PVD-DM-), (PVD = peripheral vascular
disease, DM = diabetes mellitus).
is significantly higher in diabetic patients
than in groups without DM.
Table 1 shows the results of testing
the difference in antioxidant enzyme ac-
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Fig. 2. Distribution of serum catalase activity for four observed subject groups: with PVD and with
DM (PVD+DM+), with PVD and without DM (PVD+DM-), without PVD and with DM (PVD-DM+),
and without PVD and without DM (PVD-DM-), (PVD = peripheral vascular disease, DM = diabetes
mellitus).
Fig. 3. Distribution of serum total antioxidant status (TAS) activity for four observed subject groups:
with PVD and with DM (PVD+DM+), with PVD and without DM (PVD+DM-), without PVD and
with DM (PVD-DM+), and without PVD and without DM (PVD-DM-), (PVD = peripheral vascular
disease, DM = diabetes mellitus).
tivity between diabetic and non-diabetic
patients using the Mann-Whitney test.
Statistically significant difference has
been found between diabetic and non-dia-
betic patients for all four assessed param-
eters.
Table 2 shows the results of testing
the difference in antioxidant enzyme ac-
tivity between patients with and without
PVD, only in groups with DM, using the
Mann-Whitney test. Statistically signifi-
cant difference has been found between
PVD+ and PVD- patients inside the dia-
betic group for catalase enzyme. There
was no significant difference for the re-
maining three enzymes.
Table 3 shows the results of testing
the difference in antioxidant enzyme ac-
tivity between patients with and without
PVD, only in the non-diabetic group and
the healthy group, using the Mann-Whit-
ney test. There was no significant differ-
ence between PVD+ and PVD- patients
inside the non-diabetic group and the
healthy group.
Discussion
Vascular complications as consequen-
ces from atherosclerosis are the main ca-
uses for infection and death in DM. Dia-
betic patients suffer more instances of
coronary disease, stroke, and PVD even
without other risk factors8. In recent years,
there have been many discussions about
the possible role of oxidative stress in
pathogenesis and progression of diabetic
microvascular and macrovascular com-
plications9. Many studies have shown the
presence of oxidative stress in both types
of DM through increased production of
free radicals and decreased antioxidant
defense6,9. There is a lot of evidence that
based on different characteristics of the
oxidative stress; its increased presence in
DM can be proven10.
Free radicals are very unstable due to
their high reactivity9,11. Due to their na-
ture, they have a short lifetime and are
difficult to measure and accurately deter-
mine in vivo, as well as in biological ma-
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Fig. 4. Distribution of serum superoxide dismutaze (SOD) activity for four observed subject groups:
with PVD and with DM (PVD+DM+), with PVD and without DM (PVD+DM-), without PVD and
with DM (PVD-DM+), and without PVD and without DM (PVD-DM-), (PVD = peripheral vascular
disease, DM = diabetes mellitus).
terial such as plasma or other body
fluids12. In clinical states, their existence
is determined by their influence on other
molecules or antioxidant mechanisms
which they cause12, so it is more reliable
to measure consequences of their actions,
mostly the decreased level of antioxidant
enzymes activity13.
Antioxidant status was evaluated
through the activity of key antioxidant
enzymes in patients with PVD with and
without DM, and in patients with DM
without PVD as well as in the healthy
control group. Results of our research in-
dicate a disturbed antioxidant status in
diabetic patients as a sign of oxidative
stress presence. Literature data also indi-
cates decreased antioxidant reserves in
DM, where oxidative stress can play an
important role in pathogenesis of diabetic
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TABLE 1
THE DIFFERENCES IN ANTIOXIDANT
ENZYMES ACTIVITY AND TOTAL ANTIOXI-
DANT STATUS (TAS) IN DIABETIC (DM+) AND
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vascular complications such as ateroscle-
rotic PVD14.
In our group of diabetic patients with
PVD we have found a decreased activity
of antioxidant enzymes, mainly catalase
and GLPX, as well as lowered TAS. How-
ever, SOD activity has been found to be
significantly increased.
Similar results were also found in the
group of diabetic patients without PVD.
Antioxidant status was equally disturbed
in diabetic patients without the regard to
PVD presence.
Similar findings were noted by Eng-
lish authors15 in young diabetic patients
that were insulin dependant, where anti-
oxidants glutation and tiol were decrea-
sed, while the SOD activity was signifi-
cantly increased, but without signs of
diabetic angiopathy. Researchers from a
biochemical research center in Barcelona,
Spain, found a significantly increased
SOD activity and a decreased GLPX ac-
tivity in diabetic children and adolescents
as compared to the control group11. Ma-
tching our results for the presence of oxi-
dative stress through changed antioxi-
dant enzymes without the regard to the
presence of macrovascular disease, San-
tini and others also found an increased
oxidative stress and decreased antioxi-
dant capacity in their diabetic patients
without the regard to the presence of
complications16. This was also confirmed
by a group of other authors12.
However, another group of authors
found an increased oxidative stress even
in patients with PVD without DM. In-
creased malondialdehyde (MDA) as an
indicator of lipid peroxidation and de-
creased tiol is significant in participants
with PVD in comparison to the control
group, even though inside the group of di-
abetic participants with microangiopat-
hy, but without PVD, MDA was signifi-
cantly higher, and tiol was lower as com-
pared to the group with PVD. The group
of diabetic patients was significantly youn-
ger, and even though they did not develop
macrovascular complications, they had a
higher level of oxidative stress than the
older participants with PVD. Authors be-
lieve that oxidative stress in young dia-
betic patients can contribute to earlier de-
velopment of macrovascular complica-
tions17. However, relationship between
the glucose concentration and lipid pero-
xidation is contradictory. Some authors
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TABLE 3
THE DIFFERENCES IN ANTIOXIDANT
ENZYMES ACTIVITY AND TOTAL ANTIOXI-
DANT STATUS (TAS) IN PATIENTS WITH AND
WITHOUT PERIPHERAL VASCULAR DISEASE
(PVD), ONLY IN THE NON-DIABETIC GROUP






























did not even find a relationship between
the glucose concentration and lipid pero-
xidation in their studies3, which allows
findings of atherosclerosis of major blood
vessels without damaging antioxidant
status seen in diabetic atherosclerotic di-
sease. In other words, it indicates that
lipid peroxidation which leads to endo-
thelium dysfunction is a complex multi
-component mechanism, which is suppor-
ted by our results in the group of non-dia-
betic patients with PVD and practically
regular antioxidant status, represented
by main antioxidant enzymes.
In our study of diabetic patients, there
was a significant decrease in TAS, as well
as in catalase and GLPX activity, which
matches most results in literature and is
a clear indicator of oxidative stress pres-
ence in DM18. However, data about some
components of antioxidant status, that is,
about the activity of antioxidant enzymes
is contradictory. Some authors note that
SOD activity is decreased when it is ex-
posed to an increased glucose concentra-
tion in vitro, while an increased activity
of a glycated erythrocyte-derived SOD is
found in erythrocytes of diabetic patie-
nts19. However, some studies have shown
that their participants under the influ-
ence of oxidative stress had an increased
lipid peroxidation, and decreased eryth-
rocyte SOD20,21.
The role of SOD in DM is considered
contradictory. Some studies, matching
our results, have shown an increased15,22,
while others have shown a decreased SOD
activity in diabetic patients23,24. Authors
in one Scandinavian study estimated oxi-
dative stress in DM type 1 without the re-
gard to the presence or absence of vascular
complications and concluded that there
was no significant difference in the levels
of SOD between the diabetic and control
group, while GLPX activity was found to
be significantly decreased in diabetic
group25.
Antioxidant enzymes behave differen-
tly in different tissues26. Applying stan-
dardized methods could improve inter-la-
boratory comparisons27.
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AKTIVNOST ANTIOKSIDATIVNIH ENZIMA U BOLESNIKA S
PERIFERNOM VASKULARNOM BOLESTI, SA I BEZ PRISUSTVA
[E]ERNE BOLESTI
S A @ E T A K
U radu je analiziran antioksidativni status u bolesnika s perifernom vaskularnom
bolesti (PVB), sa i bez prisustva {e}erne bolesti ([B). 211 ispitanika podijeljeno je u 4
skupine: ispitanici sa PVB i [B (PVB+[B+), ispitanici sa PVB bez [B (PVB+[B-), ispi-
tanici bez PVB sa [B (PVB-[B+) i ispitanici bez PVB i [B (PVB-[B-). Dijagnoza PVB
postavljena je Doppler sonografskom obradom, koja uklju~uje mjerenje indeksa tlaka
no`nog zgloba (engl. ankle brachial index, ABI), segmentnih tlakova du` noge i CW
Doppler sonografije na tipi~nim mjestima. Antioksidativni status prikazan je odre|i-
vanjem serumske aktivnosti klju~nih antioksidativnih enzima: superoksid dismutaze
(SOD), katalaze, glutation peroksidaze (GLPX) i totalnog antioksidativnog statusa (TAS).
U skupini PVB+[B+ kao i u skupini PVB-[B+ na|ene su zna~ajno ni`e aktivnosti enzi-
ma GLPX, katalaze i TAS, dok je aktivnost SOD bila zna~ajno povi{ena. Nije postojala
statisti~ki zna~ajna razlika izme|u PVB+[B+ i PVB-[B+ skupine. Tako|er, nije bilo
zna~ajne razlike izme|u PVB+[B- i PVB-[B- skupine. Ova studija je pokazala da po-
stoji statisti~ki zna~ajna razlika u aktivnosti antioksidativnih enzima izme|u dijabe-
ti~nih i nedijabeti~nih ispitanika, bez obzira na prisustvo PVB. [tovi{e, prisutna sama,
PVB ne mijenja aktivnost klju~nih antioksidativnih enzima u usporedbi sa zdravim
individuama.
